SEC 13F Intelligence

Managers / Q2 2023 · view latest →

BRIDGER MANAGEMENT, LLC

CIK 0001166309 · 90 PARK AVENUE, 40TH FLOOR, NEW YORK, NY, 10016 · 212-918-0820

Reported Value
$300M
Q2 2023
Positions
29
Filings on Record
37
2019–present window
Filed
Aug 14, 2023
original filing

Summary

Bridger Management, LLC reported $300M in U.S.-listed holdings across 29 positions for Q2 2023.

Its largest position, UBER, represents 11.4% of the portfolio.

Compared with Q1 2023, the fund opened 11 new positions and exited 10.

Portfolio Metrics

Turnover
+26.6%
vs prior filed quarter
Top-10 Concentration
+64.5%
share of reported value
Largest Position
+11.4%
Uber Technologies
New / Exited
11 / 10
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $1.2BQ4 ’18Q1 ’19: $1.3BQ2 ’19: $1.3BQ3 ’19: $1.2BQ4 ’19: $1.4BQ4 ’19Q1 ’20: $864MQ2 ’20: $1.1BQ3 ’20: $1.3BQ4 ’20: $1.3BQ4 ’20Q1 ’21: $1.1BQ2 ’21: $1.1BQ3 ’21: $855MQ4 ’21: $773MQ4 ’21Q1 ’22: $610MQ2 ’22: $444MQ3 ’22: $330MQ4 ’22: $247MQ4 ’22Q1 ’23: $268MQ2 ’23: $300MQ3 ’23: $272MQ4 ’23: $260MQ4 ’23Q1 ’24: $222MQ2 ’24: $194MQ3 ’24: $200MQ4 ’24: $186MQ4 ’24Q1 ’25: $201MQ2 ’25: $170MQ3 ’25: $186MQ4 ’25: $156MQ4 ’25Q1 ’26: $128Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 80.3%ADR: 11.8%Other: 8.0%Equity WRT: 0.0%
  • Common Stock · 80.3% · $241M
  • ADR · 11.8% · $35M
  • Other · 8.0% · $24M
  • Equity WRT · 0.0% · $25,760

Quarter-over-Quarter Changes full breakdown →

vs Q1 2023 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
VRTXVERTEX PHARMACEUTICALS INCNEW+42.4K42.4K+$15M$15M
BBWIBATH & BODY WORKS INCNEW+372.1K372.1K+$14M$14M
LLYLILLY ELI & CONEW+28.1K28.1K+$13M$13M
USFDUS FOODS HLDG CORPNEW+246.4K246.4K+$11M$11M
CTLTEURCATALENT INCNEW+241.3K241.3K+$10M$10M
IMGNEURIMMUNOGEN INCNEW+467.2K467.2K+$9M$9M
BLCOBAUSCH PLUS LOMB CORPNEW+245.4K245.4K+$5M$5M
SHCSOTERA HEALTH CONEW+260.4K260.4K+$5M$5M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2023

28 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1UBERUBER TECHNOLOGIES INChistory →COM11.42%$34M794.6K
2MELCO RESORTS AND ENTMNT LTDADR7.99%$24M1.97M
3CZRCAESARS ENTERTAINMENT INC NEhistory →COM7.88%$24M464.5K
4GDDYGODADDY INChistory →CL A6.75%$20M269.8K
5CHTRCHARTER COMMUNICATIONS INC Nhistory →CL A6.23%$19M50.9K
6DWDMORGAN STANLEYhistory →COM NEW5.17%$16M181.9K
7ALCON AGORD SHS4.98%$15M182.0K
8VRTXVERTEX PHARMACEUTICALS INChistory →COM4.97%$15M42.4K
9BBWIBATH & BODY WORKS INChistory →COM4.65%$14M372.1K
10BIIBBIOGEN INChistory →COM4.42%$13M46.6K
11LLYLILLY ELI & COhistory →COM4.38%$13M28.1K
12BMRNBIOMARIN PHARMACEUTICAL INChistory →COM4.13%$12M143.0K
13TEVATEVA PHARMACEUTICAL INDS LTDhistory →SPONSORED ADS3.76%$11M1.50M
14USFDUS FOODS HLDG CORPhistory →COM3.61%$11M246.4K
15CTLTEURCATALENT INChistory →COM3.48%$10M241.3K
16IMGNEURIMMUNOGEN INChistory →COM2.94%$9M467.2K
17DCBODOCEBO INChistory →COM1.83%$5M138.6K
18BLCOBAUSCH PLUS LOMB CORPhistory →COMMON SHARES1.64%$5M245.4K
19SHCSOTERA HEALTH COhistory →COM1.63%$5M260.4K
20CCKCROWN HLDGS INChistory →COM1.59%$5M55.1K
21FLAME ACQUISITION CORPCOM CL A1.52%$5M443.0K
22QTRXQUANTERIX CORPhistory →COM1.16%$3M154.9K
23WILLIAMS ROWLAND ACQUISITIONCOM1.03%$3M297.0K
24KNFKNIFE RIVER CORPCOMMON STOCK0.99%$3M68.2K
25RETAEURREATA PHARMACEUTICALS INCCL A0.84%$3M24.8K
26GOOGLALPHABET INCCAP STK CL A0.55%$2M13.9K
27UNIQURE NVSHS0.42%$1M111.0K
28SRZNWSURROZEN INCCOM · *W EXP 08/01/2030.02%$59,694528.4K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$128M24May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$156M24Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$186M28Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$170M25Aug 11, 202513F-HRchanges · EDGAR ↗
Q1 2025$201M29May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$186M28Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$200M29Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$194M28Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$222M31May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$260M28Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$272M31Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$300M29Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$268M28May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$247M23Feb 15, 202313F-HRchanges · EDGAR ↗
Q3 2022$330M44Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$444M43Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$610M52May 13, 202213F-HRchanges · EDGAR ↗
Q4 2021$773M44Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$855M46Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$1.1B44Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$1.1B42May 14, 202113F-HRchanges · EDGAR ↗
Q4 2020$1.3B39Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$1.3B36Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$1.1B35Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$864M36May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$1.4B35Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$1.2B30Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$1.3B31Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$1.3B33May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$1.2B34Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.